High-sensitivity blood tests to measure troponin — a biomarker of heart cell damage — can be used to rule out…
Lindsey Shapiro, PhD
Lindsey earned her PhD in neuroscience from Emory University in Atlanta, where she studied novel therapeutic strategies for treatment-resistant forms of epilepsy. She was awarded a fellowship from the American Epilepsy Society in 2019 for this research. Lindsey also previously worked as a postdoctoral researcher, studying the role of inflammation in epilepsy and Alzheimer’s disease.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Lindsey Shapiro, PhD
The main part of a Phase 2 trial testing Acelink Therapeutics‘ AL01211 in men with Fabry disease is now…
Analyses of kidney cells collected from urine samples could offer new ways of diagnosing Fabry disease and monitoring responses…
Serious complications like cardiovascular disease and other heart issues, kidney problems, and stroke are common among adults with Fabry…
Changes in the cornea are found in the eyes of people with Fabry disease who have a common disease…
A type of bone tissue death called avascular necrosis is a rare and painful complication of Fabry disease that…
Technologies using artificial intelligence (AI) have the ability to facilitate earlier diagnoses and better treatment for people living with…
Distinct groups of inflammatory proteins may contribute to the progression of heart problems in men and women with Fabry…
The case of a South African man diagnosed with hypertrophic cardiomyopathy (HCM), a disease of the heart muscle, who was…
In interviews, people living with Fabry disease in Spain reported a number of unmet needs — among them a…